Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

BMC Cancer. 2019 Jun 24;19(1):615. doi: 10.1186/s12885-019-5828-5.

2.

Prognostic Value of Quality of Life in Endocrine Therapy for Elderly Patients With Breast Cancer: A Retrospective Study.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Jun;39(6):2941-2950. doi: 10.21873/anticanres.13424.

PMID:
31177133
3.

Super-elderly patient-specific perioperative complications in breast cancer surgery.

Ogawa Y, Ikeda K, Watanabe C, Kamei Y, Goto W, Shiraishi C, Tokunaga S, Tsuboguchi Y.

Surg Today. 2019 Apr 22. doi: 10.1007/s00595-019-01812-x. [Epub ahead of print]

PMID:
31011870
4.

Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy.

Takada K, Kashiwagi S, Fukui Y, Goto W, Asano Y, Morisaki T, Takashima T, Hirakawa K, Ohira M.

BJS Open. 2018 Nov 26;3(1):38-47. doi: 10.1002/bjs5.50108. eCollection 2019 Feb.

5.

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.

Nakayama T, Eda M, Hirano M, Goto W.

Hum Vaccin Immunother. 2019;15(5):1139-1144. doi: 10.1080/21645515.2019.1578591. Epub 2019 Apr 22.

6.

[A Case of Breast Neuroendocrine Carcinoma].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2432-2434. Japanese.

PMID:
30692488
7.

[A Case of a Malignant Phyllodes Tumor That Was Difficult to Distinguish from Stromal Sarcoma].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2429-2431. Japanese.

PMID:
30692487
8.

[A Case of Multiple Lung Metastases from Breast Cancer Successfully Treated with Endocrine Therapy].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2426-2428. Japanese.

PMID:
30692486
9.

[A Case of Male Breast Cancer Suspected of Breast Metastasis from Pancreatic Cancer].

Takada K, Kashiwagi S, Amano R, Goto W, Asano Y, Ohira G, Yamazoe S, Kimura K, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1857-1859. Japanese.

PMID:
30692377
10.

[A Case of Invasive Ductal Carcinoma with Paget's Disease of the Breast].

Asano Y, Kashiwagi S, Goto W, Takada K, Ishihara S, Tauchi Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1842-1844. Japanese.

PMID:
30692372
11.

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2019 Jan 7;17(1):13. doi: 10.1186/s12967-019-1773-y.

12.

Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2018 Nov 19;16(1):318. doi: 10.1186/s12967-018-1692-3.

13.

Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Hirakawa K, Ohira M.

BMC Cancer. 2018 Nov 19;18(1):1137. doi: 10.1186/s12885-018-5051-9.

14.

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy.

Goto W, Kashiwagi S, Takada K, Asano Y, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2018 Nov 9;16(1):307. doi: 10.1186/s12967-018-1679-0.

15.

Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

ESMO Open. 2018 Aug 30;3(6):e000305. doi: 10.1136/esmoopen-2017-000305. eCollection 2018.

16.

Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Br J Cancer. 2018 Aug;119(5):572-579. doi: 10.1038/s41416-018-0197-4. Epub 2018 Jul 23.

PMID:
30033444
17.

Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Morisaki T, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1547-1559. doi: 10.1007/s00432-018-2670-0. Epub 2018 May 19.

18.

Eribulin Promotes Antitumor Immune Responses in Patients with Locally Advanced or Metastatic Breast Cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Fujita H, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 May;38(5):2929-2938.

PMID:
29715119
19.

Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer.

Iimori N, Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Hirakawa K, Ohira M.

In Vivo. 2018 May-Jun;32(3):669-675.

20.

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Apr 3;16(1):86. doi: 10.1186/s12967-018-1460-4.

21.

Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression.

Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Morisaki T, Fujita H, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Apr 4;16(1):87. doi: 10.1186/s12967-018-1458-y.

22.

Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes.

Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 Apr;38(4):2311-2321.

PMID:
29599354
23.

Analysis of HER Family (HER1-4) Expression as a Biomarker in Combination Therapy with Pertuzumab, Trastuzumab and Docetaxel for Advanced HER2-positive Breast Cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Morisaki T, Fujita H, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 Apr;38(4):2285-2294.

PMID:
29599351
24.

Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Biomark Res. 2018 Mar 7;6:9. doi: 10.1186/s40364-018-0124-0. eCollection 2018.

25.

Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment.

Kashiwagi S, Tsujio G, Asano Y, Goto W, Takada K, Takahashi K, Morisaki T, Fujita H, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Mar 9;16(1):54. doi: 10.1186/s12967-018-1443-5.

26.

[A Case of Bladder Metastasis from Breast Cancer].

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1933-1935. Japanese.

PMID:
29394825
27.

[A Case of Breast Cancer Associated with Dermatitis That Was Difficult to Differentiate from Dermatomyositis].

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1930-1932. Japanese.

PMID:
29394824
28.

[Experience with Using the EnCor ENSPIRE®System in Mammary Tissue Biopsy].

Sera T, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1832-1834. Japanese.

PMID:
29394791
29.

[Prognostic Analysis of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy Using QOL-ACD].

Fukui Y, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1092-1094. Japanese.

PMID:
29394544
30.

[A Case of Ductal Carcinoma In Situ in Sclerosing Adenosis].

Fukui Y, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1089-1091. Japanese.

PMID:
29394543
31.

[A Case of Synchronous Triple Cancer of the Breast, Duodenal and Lung].

Takada K, Kashiwagi S, Amano R, Goto W, Asano Y, Ohira G, Kimura K, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1074-1076. Japanese.

PMID:
29394538
32.

[A Case of Adenoma of the Nipple Suspected of Breast Cancer].

Takada K, Kashiwagi S, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1071-1073. Japanese.

PMID:
29394537
33.

[A Case of T1a Breast Cancer with Axillary Lymph Node Metastasis].

Tsujio G, Kashiwagi S, Asano Y, Goto W, Takada K, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1059-1061. Japanese.

PMID:
29394533
34.

[A Case of Breast Cancer with Local Recurrence in the Reconstructed Breast Tissue].

Tsujio G, Kashiwagi S, Hatano T, Asano Y, Goto W, Takada K, Noda S, Takashima T, Onoda N, Motomura H, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1056-1058. Japanese.

PMID:
29394532
35.

Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden.

Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Hatano T, Noda S, Takashima T, Onoda N, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

BMC Cancer. 2017 Dec 28;17(1):888. doi: 10.1186/s12885-017-3927-8.

36.

Mesenchymal-epithelial Transition and Tumor Vascular Remodeling in Eribulin Chemotherapy for Breast Cancer.

Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Hatano T, Tanaka S, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 Jan;38(1):401-410.

PMID:
29277801
37.

Using TILs to Predict Therapeutic Effect of Chemotherapy (Pertuzumab, Trastuzumab, Docetaxel) on HER2-positive Breast Cancer.

Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2017 Oct;37(10):5623-5630.

PMID:
28982879
38.

Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer.

Kashiwagi S, Fukushima W, Asano Y, Goto W, Takada K, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

BMC Cancer. 2017 Aug 31;17(1):604. doi: 10.1186/s12885-017-3598-5.

39.

Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Biomark Res. 2017 May 12;5:19. doi: 10.1186/s40364-017-0099-2. eCollection 2017. Erratum in: Biomark Res. 2018 Mar 7;6:9.

40.

Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.

Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Noda S, Takashima T, Onoda N, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

PLoS One. 2017 Feb 6;12(2):e0170634. doi: 10.1371/journal.pone.0170634. eCollection 2017.

41.

[A Case of Malignant Phyllodes Tumor Difficult to Distinguish from Spindle Cell Carcinoma].

Okazaki Y, Kashiwagi S, Asano Y, Goto W, Takada K, Morisaki T, Takashima T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2243-2245. Japanese.

PMID:
28133283
42.

[Pathological Complete Response Obtained by Eribulin Chemotherapy in a Case of Advanced Breast Cancer].

Asano Y, Kashiwagi S, Goto W, Takada K, Morisaki T, Takashima T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2240-2242. Japanese.

PMID:
28133282
43.

[A Case of Inflammatory Pseudotumor of the Mammary Gland].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Takashima T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2029-2031. Japanese.

PMID:
28133211
44.

Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report.

Sera T, Kashiwagi S, Takashima T, Asano Y, Goto W, Iimori N, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

BMC Res Notes. 2017 Jan 19;10(1):55. doi: 10.1186/s13104-017-2375-5.

45.

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer.

Asano Y, Kashiwagi S, Goto W, Tanaka S, Morisaki T, Takashima T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Cancers (Basel). 2017 Jan 6;9(1). pii: E4. doi: 10.3390/cancers9010004.

46.

Current prescription status of antihypertensive drugs with special reference to the use of diuretics in Japan.

Ibaraki A, Goto W, Iura R, Tominaga M, Tsuchihashi T.

Hypertens Res. 2017 Feb;40(2):203-206. doi: 10.1038/hr.2016.120. Epub 2016 Sep 1.

PMID:
27581534
47.

Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer.

Asano Y, Kashiwagi S, Goto W, Kurata K, Noda S, Takashima T, Onoda N, Tanaka S, Ohsawa M, Hirakawa K.

Br J Surg. 2016 Jun;103(7):845-54. doi: 10.1002/bjs.10127. Epub 2016 Mar 8.

PMID:
26953091
48.

[A Case of Spontaneous Regression of Breast Cancer with Multiple Lung Metastases].

Asano Y, Kashiwagi S, Goto W, Kurata K, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1800-2. Japanese.

PMID:
26805177
49.

[A case of radical resection for pancreatic head cancer with peritoneal dissemination treated with combination chemotherapy].

Nakajima T, Tsukamoto T, Kanazawa A, Shimizu S, Sakae M, Ohira G, Yoshii M, Ishikawa A, Mori Y, Kotsuka M, Goto W, Kurihara S, Tashima T, Deguchi S, Tachimori A, Tamamori Y, Yamamoto A, Inoue T, Yamashita Y, Nishiguchi Y.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2181-3. Japanese.

PMID:
25731463
50.

[Two cases of neuroendocrine tumors of the pancreas with multiple liver metastases treated by use of degradable starch microspheres and octreotide].

Goto W, Shimizu S, Kotsuka M, Sakae M, Kanazawa A, Tsukamoto T, Yamashita Y, Nishiguchi Y.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2139-41. Japanese.

PMID:
25731449

Supplemental Content

Support Center